In a recent review published in the journal Cell, researchers discussed advancements in ribonucleic acid (RNA)-comprising lipid nanoparticle (LNP)-based immunotherapies for cancer and the improvements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results